KLK4 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5109888-Each-of-1 | In Stock | ₹ 46,324.50 |
PIPA5109888 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,324.50
GST (18%): ₹ 8,338.41
Total Price: ₹ 54,662.91
Antigen
KLK4
Classification
Polyclonal
Conjugate
Unconjugated
Gene
KLK4
Gene Alias
AI2A1; androgen-regulated message 1; ARM1; EMSP; Emsp1; enamel matrix serine protease 1; Enamel matrix serine proteinase 1; ESMP1; kallikrein; kallikrein 4 (prostase, enamel matrix, prostate); kallikrein related peptidase 4; kallikrein related-peptidase 4 (prostase, enamel matrix, prostate); kallikrein-4; Kallikrein-like protein 1; kallikrein-related peptidase 4; Klk4; KLK-4; KLKL1; KLK-L1; Prostase; protease, serine 17 (enamel matrix, prostate); Prss17; PSTS; serine protease 17
Host Species
Rabbit
Purification Method
Affinity Chromatography
Regulatory Status
RUO
Gene ID (Entrez)
408210, 56640, 9622
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Immunocytochemistry, Western Blot
Concentration
0.49 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3
Gene Accession No.
Q9Y5K2, Q9Z0M1
Gene Symbols
KLK4
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 30-254 of human KLK4 (NP_004908.4).
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Immunogen sequence: QIINGEDCSP HSQPWQAALV MENELFCSGV LVHPQWVLSA AHCFQNSYTI GLGLHSLEAD QEPGSQMVEA SLSVRHPEYN RPLLANDLML IKLDESVSES DTIRSISIAS QCPTAGNSCL VSGWGLLANG RMPTVLQCVN VSVVSEEVCS KLYDPLYHPS MFCAGGGQDQ KDSCNGDSGG PLICNGYLQG LVSFGKAPCG QVGVPGVYTN LCKFTEWIEK TVQAS Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis
- A novel Kallikrein gene Prostase/KLK-L1 (also known as KLK4) is expressed and is up-regulated by androgens and progestins
- KLK-L1 may be involved in the pathogenesis and/or progression of prostate, breast, and possibly other malignancies.